The intersection of trends in HCIT and Life Sciences technology is a core thesis that we continue to applaud. These intersecting technologies not only allow providers to understand patients better, but can also deliver customized experiences in addition to elevating health care engagement.
HCIT & Life Sciences
Transactions
AGC Partners acted as sole financial advisor to Curoverse